NCT05546723
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
Clinical trial condition
Multiple Myeloma, Refractory
Explore clinical trials studying Multiple Myeloma, Refractory. Study availability and eligibility vary by location and protocol.
21 public trials
13 recruiting studies
Multiple Myeloma, Refractory trial results
NCT04657861
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- The First Affiliated Hospital，College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT04603872
- Conditions
- Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphocytic Leukaemia Refractory, Blood Protein Disorders, +28 more
- Locations
-
- The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China
Not Yet Recruiting
Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma
NCT07611149
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
Not Yet Recruiting
Carfilzomib, Oral Cyclophosphamide, and Dexamethasone for RRMM
NCT05909826
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
NCT04813653
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Tel Aviv Sourasky Medical Center Tel Aviv, Israel
NCT05555329
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- VUMedicalCenter Amsterdam, Netherlands
NCT06012383
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
NCT04811898
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Blood Protein Disorders, +24 more
- Locations
-
- Center for Phase I Clinical Studies in Medical Oncology and Oncohematology - Translational Medical Oncology Unit, AOU MaterDomini and Magna Graecia University Catanzaro, Italy
Completed
Study of Pomalidomide, Cyclophosphamide, Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT02176213
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States